InvestorsHub Logo
Followers 14
Posts 1740
Boards Moderated 0
Alias Born 02/07/2018

Re: MSDR post# 16048

Friday, 10/23/2020 5:58:08 PM

Friday, October 23, 2020 5:58:08 PM

Post# of 18220
I don’t think a reverse split is necessary and IMUN will probably just be absorbed into CBLI into CYTO that is already on the Nasdaq. How many shares of CYTO you get will be determined by the board. For every 10,000 or 1,000 shares of IMUN you have you get 1 share of CYTO depending on the share price at a certain date? That’s how I see it working... IMUN can’t list themselves in the Nasdaq. It’s pipeline and revenue all will run through Cytocom based on the past reports. It doesn’t mean it’s not a good investment, it’s a way to own a piece of CYTO / CBLI prior to the Merger. We find out more on Wednesday. Until then, we’re all speculating!...